Getting Companies To Discuss Their Pediatric Research Plans Early: EMA Pilot Finally Gets Off To A Start
This article was originally published in SRA
Executive Summary
Interest is finally to beginning to pick up in the European Medicines Agency's pilot project on offering early scientific advice to drug sponsors to support the development of pediatric medicines. The pilot had initially drawn a lukewarm response from pharmaceutical companies, who showed reluctance to discuss their pediatric research plans with the agency at an early stage.
You may also be interested in...
Parallel EMA-FDA Pediatric Advice On The Cards For Companies
The European Medicines Agency is working on plans to supplement its early advice pilot on pediatric development by providing joint advice with the US FDA and, in some cases, by arranging for a three-way dialogue with companies.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.